Literature DB >> 8832026

Fatal autoimmune pancytopenia following bone marrow transplantation for aplastic anaemia.

C De Lord1, J C Marsh, J G Smith, C R Singer, E C Gordon-Smith.   

Abstract

We report a case of autoimmune pancytopenia 10 months after allogeneic bone marrow transplantation (BMT) for severe aplastic anaemia (SAA). The autoimmune haemolytic anaemia (AIHA) and immune thrombocytopenic purpura (ITP) were refractory to conventional immunosuppressive therapy which included steroids, azathioprine, vincristine and intravenous immunoglobulin. Splenectomy led to a recovery of the thrombocytopenia but the haemolysis continued despite further immunosuppressive therapy. Four months after the onset of haemolysis granulocyte-specific antibodies were detected. The patient subsequently received total lymph node irradiation (TLI) with a peripheral blood stem cell transplant (PBSCT) from his original donor, but died 9 days later from cerebral aspergillosis. The severe nature of autoimmune cytopenias and their lack of response to conventional treatment following allogeneic BMT is discussed further.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8832026

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  5 in total

1.  Severe autoimmune thrombocytopenia after allogeneic bone marrow transplantation for aplastic anemia.

Authors:  A Tomonari; A Tojo; T Lseki; J Ooi; H Nagayama; K Ogami; T Maekawa; N Shirafuji; K Tani; S Asano
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

2.  Splenectomy for severe autoimmune cytopenias after allogenic stem cell transplantation: case report.

Authors:  Irena Proleznik; Hugh Grant Prentice; Joze Pretnar; Samo Zver; Peter Cernelc
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

Review 3.  Autoimmune hemolytic anemia.

Authors:  C Hashimoto
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

4.  Characterizing Immune-Mediated Cytopenias After Allogeneic Hematopoietic Cell Transplantation for Pediatric Nonmalignant Disorders.

Authors:  Robert T Galvin; Qing Cao; Weston P Miller; Jessica Knight-Perry; Angela R Smith; Christen L Ebens
Journal:  Transplant Cell Ther       Date:  2021-01-20

Review 5.  Successful treatment of severe immune hemolytic anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature.

Authors:  Sakura Hosoba; David L Jaye; Cynthia Cohen; John D Roback; Edmund K Waller
Journal:  Transfusion       Date:  2014-08-25       Impact factor: 3.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.